NCT07113366CompletedPhase 1
Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic Dermatitis
Improvement of Atopic Dermatitis Symptoms and Signs by Jelly Fig (Ficus Awkeotsang Makino) Extract
Source: ClinicalTrials.gov · Last updated 8 Aug 2025
Brief summary (registry, in English)
The study is designed to evaluate the efficacy and safety of a topical formulation containing Ficus awkeotsang Makino extract (FAE), derived from jelly fig, in participants with mild to moderate atopic dermatitis. Ficus awkeotsang is a traditional plant native to Taiwan.
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 25 Jul 2025
- Start date
- 1 May 2024
- Primary completion date
- 1 Jun 2024
- Lead sponsor
- Kaohsiung Veterans General Hospital.
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07113366
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 30
- From 1 May 2024 to the primary completion date, 1 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior treatment with biologic agents within 16 weeks before baseline
- Use of phototherapy, systemic corticosteroids, or other systemic immunosuppressants within 28 days before baseline
- Use of topical corticosteroids (TCS) or topical calcineurin inhibitors (TCI) within 14 days before baseline
- Known hypersensitivity to any component of the investigational product
Other illness
- Presence of active skin infections
Other
- Pregnancy or breastfeeding
Who the study is looking for
- Age ≥12 years at the time of enrollment
- Clinical diagnosis of atopic dermatitis (AD) according to the Hanifin and Rajka criteria
- Investigator's Global Assessment (IGA) score of 2 (mild) or 3 (moderate) at screening
Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kaohsiung Veterans General Hospital Coordinator of this site? Confirm its status | Kaohsiung City | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.